References and Notes
1a
Ramesh M.
Mohan PS.
Shanmugam P.
Tetrahedron
1984,
40:
4041
1b Witherup KM, Ranson RW, Varga SL, Lotti VJ, and Lumma WJ. inventors; U.S. Patent US 5288725.
; Chem. Abstr. 1994, 121, 91779s
1c
Johnson JV.
Eauckman S.
Baccanari PD.
Roth B.
J. Med. Chem.
1989,
32:
1942
1d Biller SA, and Misra RN. inventors; U.S. Patent US 4843082.
; Chem. Abstr. 1989, 111, 232600j
1e
Perry NB.
Blunt JW.
McComb JD.
Munro MHG.
J. Org. Chem.
1986,
51:
5476
1f
Yamada N.
Kadowaki S.
Takahashi K.
Umezu K.
Biochem. Pharmacol.
1992,
44:
1211
1g
Faber K.
Stuckler H.
Kappe T.
J. Heterocyl. Chem.
1984,
21:
1177
1h
Michael ZH.
Roger LX.
Richard FR.
Sylvia M.
Alban S.
Gregory DC.
James RH.
Bioorg. Med. Chem. Lett.
2002,
12:
129
1i
Lin H.-ML.
Liu F.-W.
Zou D.-P.
Dai G.-F.
Bioorg. Med. Chem. Lett.
2005,
15:
1821
2
Katritzky AR.
Rachwal S.
Rachwal B.
Tetrahedron
1996,
48:
15031 ; and references cited therein
3a
Povarov LS.
Russ. Chem. Rev. (Engl. Transl.)
1967,
36:
656
3b
Boger DL.
Weinreb SM.
Hetero Diels-Alder Methodology in Organic Synthesis
Academic Press;
San Diego:
1987.
Chap. 2.
3c
Boger DL.
Weinreb SM.
Hetero Diels-Alder Methodology in Organic Synthesis
Academic Press;
San Diego:
1987.
Chap. 9.
3d
Weinreb SM.
In Comprehensive Organic Synthesis
Vol. 5:
Trost BM.
Fleming I.
Pergamon;
Oxford:
1991.
p.401
3e
Buonora P.
Olsen JC.
Oh T.
Tetrahedron
2001,
57:
6099
3f
Jayakumar S.
Ishar MPS.
Mahajan MP.
Tetrahedron
2002,
58:
379
3g
Zang J.
Li C.-J.
J. Org. Chem.
2002,
67:
3969
3h
Cheng D.
Zhou J.
Saiah E.
Beaton G.
Org. Lett.
2002,
4:
4411
3i
Sundarajan G.
Prabagaran N.
Varghese B.
Org. Lett.
2001,
3:
1973
3j
Lavilla R.
Bernabeu MC.
Carranco I.
Diaz JL.
Org. Lett.
2003,
5:
717
3k
Yadav JS.
Reddy BVS.
Reddy JSS.
Rao S.
Tetrahedron
2003,
59:
1599
3l
Jose B.
Monica T.
Eduardo R.
Jose MG.
J. Am. Chem. Soc.
2004,
126:
3416
3m
Xia M.
Lu Y.-D.
Synlett
2005,
2357
4a
Zhang W.
Jia X.
Yang Li.
Liu Z.-L.
Tetrahedron Lett.
2002,
43:
9433
4b
Zhang W.
Guo Y.
Liu Z.
Jin X.
Yang Li.
Liu Z.-L.
Tetrahedron
2005,
61:
1325
5
Yadav JS.
Reddy BVS.
Sadasiv K.
Reddy PSR.
Tetrahedron Lett.
2002,
43:
3853
6a
Kobayashi S.
Nagayama S.
J. Am. Chem. Soc.
1996,
118:
8977
6b
Kiselyov A.
Smith L.
Virgilio A.
Armstrong RW.
Tetrahedron
1998,
54:
7987
6c
Kobayashi S.
Akiyama R.
Pure Appl. Chem.
2001,
73:
1103
7
Powell DA.
Batey RA.
Tetrahedron Lett.
2003,
44:
7569
8a
Dilman AD.
Loffe SL.
Chem. Rev.
2003,
103:
733
8b
Lee PH.
Seomoon D.
Lee K.
Heo Y.
J. Org. Chem.
2003,
68:
2510
8c
Wang L.-S.
Hollis TK.
Org. Lett.
2003,
14:
2543
8d
Liu Y.
Xu X.
Zhang Y.
Tetrahedron
2004,
60:
4867
8e
Sabitha G.
Reddy GSK.
Reddy KB.
Yadav JS.
Synthesis
2004,
263
8f
Sabitha S.
Reddy KS.
Reddy GSK.
Fatima N.
Yadav JS.
Synlett
2005,
2347
8g
Barga AL.
Vargas F.
Sehnem JA.
Barga RC.
J. Org. Chem.
2005,
70:
9021
8h
Xu L.-W.
Xia C.-G.
Synthesis
2004,
2191
9
Wang T.
Zhang Z.
Meanwell NA.
Tetrahedron Lett.
1999,
40:
6745
10
Tsuji R.
Nakagawa M.
Nishida A.
Tetrahedron: Asymmetry
2003,
14:
177
11
General Procedure for the Synthesis of Pyrano- and Furanoquinolines 8a and 8b.
A mixture of aldehyde 5 (1 mmol), aniline 6 (1.2 mmol), olefin 7 (1.2 mmol) and TMSCl (20 mol%) in MeCN (1 mL) was stirred at r.t. for an appropriate time (Table
[2]
). After completion of the reaction (monitored by TLC), the reaction mixture diluted with EtOAc (25 mL) and washed with H2O (2 × 20 mL) followed by brine (2 × 15 mL). The organic layer was dried over anhyd MgSO4, followed by evaporation of solvent to obtain the crude product. Pure product 8 was obtained by flash column chromatography on silica gel using eluent (hexane-EtOAc, 95:5).
Synthesis of Pyranoquinolines 11a and 11b.
A mixture of aniline 2 (1 mmol), 3,4-dihydro-2H-pyran (3, 2.2 mmol) and TMSCl (20 mol%) in MeCN (1 mL) was stirred at r.t. for 3 h. The products were obtained as above.
Compound 8a from Table 2, Entry 17.
White solid, mp 108-110 °C. 1H NMR (200 MHz, CDCl3): δ = 1.78-1.81 (1 H, m), 2.30-2.33 (1 H, m), 2.80-2.83 (1 H, m), 3.78-3.81 (2 H, m), 3.96 (1 H, br s), 4.95 (1 H, d, J = 2.6 Hz), 5.25 (1 H, d, J = 7.6 Hz), 6.58 (1 H, d, J = 8.0 Hz), 6.84 (1 H, t, J = 7.4 Hz), 7.04-7.06 (3 H, m), 7.24 (1 H, d, J = 5.2 Hz), 7.34 (1 H, d, J = 7.2 Hz). 13C NMR (50 MHz, CDCl3): δ = 145.36, 144.30, 129.97, 128.26, 126.53, 124.12, 123.95, 122.61, 119.45, 114.85, 75.61, 66.50, 53.53, 45.85, 25.07. MS (70 eV): m/z (%) = 258 (8) [M + 1]+, 257 (55) [M+], 212 (100), 178 (25), 130 (23), 115 (22), 91 (25), 77 (28). HRMS: m/z calcd for C15H15NOS: 257.0874; found: 257.0869.
Compound 8b from Table 2, Entry 17.
White solid, mp 146-148 °C. 1H NMR (200 MHz, CDCl3): δ = 1.86-1.89 (1 H, m), 2.12-2.16 (1 H, m), 2.45-2.48 (1 H, m), 3.85-3.89 (1 H, m), 4.04-4.08 (1 H, m), 4.14 (1 H, d, J = 11.0 Hz), 4.31 (1 H, br s), 4.60 (1 H, d, J = 4.6 Hz), 6.65 (1 H, d, J = 8.0 Hz), 6.84 (1 H, t, J = 7.4 Hz), 6.99-7.16 (3 H, m), 7.29-7.40 (2 H, m). 13C NMR (50 MHz, CDCl3): δ = 145.34, 144.63, 131.07, 128.90, 126.41, 125.80, 125.27, 120.05, 118.75, 114.79, 76.02, 65.15, 53.47, 44.72, 29.03.
Compound 8a from Table 2, Entry 18.
White solid, mp 155-156 °C. 1H NMR (200 MHz, CDCl3): δ = 1.55-1.58 (4 H, m), 2.18-2.22 (1 H, m), 3.40-3.43 (1 H, m), 3.55-3.59 (1 H, m), 4.11-4.14 (1 H, m), 4.96 (1 H, d, J = 2.6 Hz), 5.29 (1 H, d, J = 5.6 Hz), 6.10 (1 H, d, J = 8.2 Hz), 6.84 (1 H, t, J = 7.4 Hz), 7.03-7.08 (3 H, m), 7.23 (1 H, d, J = 3.4 Hz), 7.43 (1 H, d, J = 7.6 Hz). 13C NMR (50 MHz, CDCl3): δ = 144.33, 144.28, 127.75, 127.29, 126.41, 123.61, 123.50, 119.84, 118.46, 114.27, 60.32, 55.35, 39.31, 25.07, 18.12. MS (70 eV): m/z (%) = 272 (5) [M + 1]+, 271 (28) [M+], 212 (100), 178 (20), 130 (22), 91 (20), 77 (22), 70 (24). HRMS: m/z calcd for C16H17NOS: 271.1031; found: 271.1025.
Compound 8b from Table 2, Entry 18.
White solid, mp 135-137 °C. 1H NMR (200 MHz, CDCl3): δ = 1.35-1.37 (1 H, m), 1.61-1.83 (3 H, m), 2.02-2.06 (1 H, m), 3.70 (1 H, t), 4.07 (1 H, d, J = 9.8 Hz), 4.37 (1 H, d, J = 2.6 Hz), 5.03 (1 H, d, J = 10.6 Hz), 6.52 (1 H, d, J = 8.2 Hz), 6.73 (1 H, t, J = 7.4 Hz), 6.95-6.97 (3 H, m), 7.21-7.24 (2 H, m). 13C NMR (50 MHz, CDCl3): δ = 146.04, 144.01, 130.70, 129.21, 126.25, 125.27, 124.89, 120.67, 117.79, 114.24, 68.64, 50.58, 40.12, 24.05, 21.80.
Compound 8a from Table 2, Entry 19.
Pale yellow solid, mp 75-77 °C. 1H NMR (200 MHz, CDCl3): δ = 1.85-1.88 (1 H, m), 2.22-2.26 (1 H, m), 2.96-2.99 (1 H, m), 3.78-3.82 (2 H, m), 3.89 (1 H, br s), 4.69 (1 H, d, J = 3.0 Hz), 5.23 (1 H, d, J = 7.6 Hz), 6.26-6.36 (2 H, m), 6.60 (1 H, d, J = 8.0 Hz), 6.83 (1 H, t, J = 7.2 Hz), 7.10 (1 H, t, J = 7.6 Hz), 7.36-7.39 (2 H, m). 13C NMR (50 MHz, CDCl3): δ = 154.80, 144.34, 141.60, 130.05, 128.31, 122.58, 119.31, 114.82, 110.19, 105.63, 75.36, 66.42, 51.48, 42.24, 25.25. MS (70 eV): m/z (%) = 242 (9) [M + 1+], 241 (55) [M+], 196 (100), 178 (25), 167 (25), 130 (22), 91 (18), 77 (27). HRMS: m/z calcd for C15H15NO2: 241.1103; found: 241.1097.
Compound 8b from Table 2, Entry 19.
Pale yellow solid, mp 62-64 °C. 1H NMR (200 MHz, CDCl3): δ = 1.83-1.86 (1 H, m), 2.12-2.16 (1 H, m), 2.63-2.65 (1 H, m), 3.84-3.87 (1 H, m), 4.01-4.05 (2 H, m), 4.29 (1 H, br s), 4.61 (1 H, d, J = 5.0 Hz), 6.34-6.38 (2 H, m), 6.63 (1 H, d, J = 8.0 Hz), 6.80 (1 H, t, J = 7.2 Hz), 7.13 (1 H, t, J = 7.2 Hz), 7.40-7.43 (2 H, m). 13C NMR (50 MHz, CDCl3): δ = 154.50, 144.40, 142.27, 130.97, 128.84, 119.99, 118.59, 114.85, 110.17, 107.41, 75.72, 65.21, 51.08, 40.66, 29.10.
Compound 8a from Table 2, Entry 20.
Brown solid, mp 151-152 °C. 1H NMR (200 MHz, CDCl3): δ = 1.44-1.60 (4 H, m), 2.30-2.40 (1 H, m), 3.40-3.51 (2 H, m), 3.89-4.02 (1 H, m), 4.71 (1 H, d, J = 2.3 Hz), 5.25 (1 H, d, J = 5.6 Hz), 6.29-6.32 (1 H, m), 6.36-6.40 (1 H, m), 6.62 (1 H, d, J = 8.0 Hz), 6.83 (1 H, t, J = 6.6 Hz), 7.08 (1 H, t, J = 6.4 Hz), 7.43 (2 H, d, J = 8.6 Hz). 13C NMR (50 MHz, CDCl3): δ = 154.03, 144.40, 141.60, 128.09, 127.69, 120.08, 118.59, 114.50, 110.16, 105.98, 71.80, 60.65, 53.74, 36.22, 25.28, 18.76. MS (70 eV): m/z (%) = 256 (7) [M + 1+], 255 (42) [M+], 196 (100), 167 (23), 130 (33), 91 (15), 81 (24), 77 (25), 70 (20). HRMS: m/z calcd for C16H17NO2: 255.1259; found: 255.1254.
Compound 8b from Table 2, Entry 20.
Pale brown solid, mp 92-94 °C. 1H NMR (200 MHz, CDCl3): δ = 1.40-1.43 (1 H, m), 1.51-1.54 (1 H, m), 1.74-1.78 (2 H, m), 2.20-2.24 (1 H, m), 3.64-3.69 (1 H, m), 4.01-4.05 (1 H, m), 4.40 (1 H, d, J = 3.0 Hz), 4.81 (1 H, d, J = 10.6 Hz), 6.31-6.35 (2 H, m), 6.53 (1 H, d, J = 8.0 Hz), 6.69 (1 H, t, J = 7.4 Hz), 7.06 (1 H, t, J = 7.6 Hz), 7.21 (1 H, d, J = 7.6 Hz), 7.38 (1 H, s). 13C NMR (50 MHz, CDCl3): δ = 155.01, 143.97, 142.00, 130.46, 129.09, 120.45, 117.64, 114.33, 110.04, 107.32, 73.89, 67.90, 48.84, 36.96, 24.18, 22.03.
Compound 8a from Table 2, Entry 23.
Pale yellow solid, mp 170-172 °C. 1H NMR (200 MHz, CDCl3): δ = 0.92-0.96 (2 H, m), 1.19-1.29 (3 H, m), 1.40-1.50 (3 H, m), 1.58-1.65 (1 H, m), 1.67-1.71 (2 H, m), 1.76-1.83 (3 H, m), 1.90-1.93 (1 H, m), 2.18-2.22 (1 H, m), 2.97 (1 H, dd, J = 7.6, 2.0 Hz), 3.38-3.45 (1 H, m), 3.56-3.60 (1 H, m), 5.02 (1 H, d, J = 5.5 Hz), 6.51 (1 H, d, J = 8.0 Hz), 6.72 (1 H, t, J = 7.3 Hz), 7.03 (1 H, t, J = 7.1 Hz), 7.36 (1 H, d, J = 7.6 Hz). 13C NMR (50 MHz, CDCl3): δ = 144.95, 127.81, 127.40, 120.06, 117.68, 113.91, 72.56, 60.58, 59.15, 37.45, 33.15, 30.20, 28.46, 26.27, 25.90, 25.83, 25.52, 17.93.
Compound 8b from Table 2, Entry 23.
Pale yellow solid, mp 115-117 °C. 1H NMR (200 MHz, CDCl3): δ = 1.13-1.20 (5 H, m), 1.49-1.53 (2 H, m), 1.64-1.84 (8 H, m), 1.95-1.97 (1 H, m), 3.23-3.27 (1 H, m), 3.63-3.69 (1 H, m), 3.83-3.87 (1 H, m), 4.50 (1 H, d, J = 3.5 Hz), 6.51 (1 H, d, J = 8.0 Hz), 6.64 (1 H, t, J = 7.8 Hz), 7.04 (1 H, t, J = 7.8 Hz), 7.24 (1 H, d, J = 7.2 Hz). 13C NMR (50 MHz, CDCl3): δ = 144.85, 129.71, 128.73, 119.91, 116.78, 114.05, 73.35, 66.12, 55.60, 38.61, 33.22, 30.23, 26.81, 26.71, 26.56, 26.28, 24.18, 23.35.